These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12918795)

  • 1. Internal exposure monitoring of 131I-radiopharmaceutical production workers in Iran.
    Alirezazadeh N; Garshasbi H; Karimi Diba J
    Radiat Prot Dosimetry; 2003; 104(2):173-6. PubMed ID: 12918795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it safe to work with iodine-131 if you are pregnant? A risk assessment for nuclear medicine staff involved with cleaning and decontamination.
    Barber RW; Parkin A; Goldstone KE
    Nucl Med Commun; 2003 May; 24(5):571-4. PubMed ID: 12717076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation exposure rate from 131I-treated hyperthyroid patients--a dynamic study, with data for up to 42 d post therapy.
    Mohammadi H
    Health Phys; 2005 May; 88(5):486-90. PubMed ID: 15824597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASSESSMENT OF INTAKE ACCORDING TO IDEAS GUIDANCE: CASE STUDY.
    Bitar A; Maghrabi M
    Radiat Prot Dosimetry; 2018 Apr; 179(2):179-183. PubMed ID: 29145639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.
    Marcus CS; Siegel JA
    J Nucl Med; 2004 Apr; 45(4):13N-6N, 37N. PubMed ID: 15073236
    [No Abstract]   [Full Text] [Related]  

  • 6. ICRP Publication 119: Compendium of dose coefficients based on ICRP Publication 60.
    ; Eckerman K; Harrison J; Menzel HG; Clement CH
    Ann ICRP; 2012; 41 Suppl 1():1-130. PubMed ID: 23025851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is radiation protection for the unborn child guaranteed by radiation protection for female workers?
    Nosske D; Karcher K
    Radiat Prot Dosimetry; 2003; 105(1-4):269-72. PubMed ID: 14526969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for authorisation of internal dosimetry services.
    Melo DR; Cunha PG; Torres MM; Lourenço MC
    Radiat Prot Dosimetry; 2003; 105(1-4):437-41. PubMed ID: 14527004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium iodate-another effective blocker of radioiodine uptake by the thyroid gland.
    Pahuja DN; Jagtap VS; Sonawane VR; Rajan MG; Samuel AM
    Health Phys; 2005 Jul; 89(1):92-4. PubMed ID: 15951696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A methodology for auto-monitoring of internal contamination by 131I in nuclear medicine workers.
    Vidal MV; Dantas AL; Dantas BM
    Radiat Prot Dosimetry; 2007; 125(1-4):483-7. PubMed ID: 17766259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THYROID EXPOSURE DURING 18F-FDG PRODUCTION PROCEDURES.
    Wrzesien M
    Radiat Prot Dosimetry; 2018 Dec; 182(4):464-471. PubMed ID: 29931185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal organ radiation dosimetry and associated uncertainties in nuclear medicine, with emphasis on iodine-131.
    Brill AB; Stabin M; Bouville A; Ron E
    Radiat Res; 2006 Jul; 166(1 Pt 2):128-40. PubMed ID: 16808602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical aspects of peptide receptor radionuclide therapy with [177Lu][DOTA0, Tyr3]octreotate.
    Bakker WH; Breeman WA; Kwekkeboom DJ; De Jong LC; Krenning EP
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):265-71. PubMed ID: 17043624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of intake and internal dose from iodine-131 for exposed workers handling radiopharmaceutical products.
    Bitar A; Maghrabi M; Doubal AW
    Appl Radiat Isot; 2013 Dec; 82():370-5. PubMed ID: 24184740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK laboratory intercomparison on internal dosimetry.
    Speed J; Birchall A; Bull R; Cockerill R; Jarvis NS; Marsh JW; Peace MS; Roberts G; Scarlett C; Spencer D; Stewart P
    Radiat Prot Dosimetry; 2003; 104(3):221-9. PubMed ID: 14565728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism.
    Matheoud R; Reschini E; Canzi C; Voltini F; Gerundini P
    Med Phys; 2004 Dec; 31(12):3194-200. PubMed ID: 15651602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation of internal contamination monitoring programme by integration of uncertainties.
    Davesne E; Casanova P; Chojnacki E; Paquet F; Blanchardon E
    Radiat Prot Dosimetry; 2011 Mar; 144(1-4):361-6. PubMed ID: 21037264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.